152 related articles for article (PubMed ID: 31980187)
21. Predictors of hypogammaglobulinemia during rituximab maintenance therapy in rheumatoid arthritis: A 12-year longitudinal multi-center study.
Boleto G; Avouac J; Wipff J; Forien M; Dougados M; Roux C; Kahan A; Dieude P; Allanore Y
Semin Arthritis Rheum; 2018 Oct; 48(2):149-154. PubMed ID: 29548542
[TBL] [Abstract][Full Text] [Related]
22. Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease.
Roberts DM; Jones RB; Smith RM; Alberici F; Kumaratne DS; Burns S; Jayne DR
J Autoimmun; 2015 Feb; 57():60-5. PubMed ID: 25556904
[TBL] [Abstract][Full Text] [Related]
23. Chronic enteroviral meningoencephalitis in a patient on rituximab for the treatment of psoriatic arthritis: A case report and brief literature review.
Tellez R; Lastinger AM; Hogg JP
IDCases; 2019; 17():e00558. PubMed ID: 31193253
[TBL] [Abstract][Full Text] [Related]
24. Intravenous versus subcutaneous immunoglobulin replacement in secondary hypogammaglobulinemia.
Spadaro G; Pecoraro A; De Renzo A; Della Pepa R; Genovese A
Clin Immunol; 2016 May; 166-167():103-4. PubMed ID: 27063866
[TBL] [Abstract][Full Text] [Related]
25. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
26. Incidence of Profound Hypogammaglobulinemia and Infection Rate in Lymphoma Patients Following the Combination of Chemotherapy and Rituximab.
Filanovsky K; Miller EB; Sigler E; Berrebi A; Shvidel L
Recent Pat Anticancer Drug Discov; 2016; 11(2):228-35. PubMed ID: 26825174
[TBL] [Abstract][Full Text] [Related]
27. [Recurrent infections in an ITP patient treated with rituximab].
Rosenberg-Bezalel S; Asher I; Sthoeger Z
Harefuah; 2012 Nov; 151(11):617-9, 655. PubMed ID: 23367730
[TBL] [Abstract][Full Text] [Related]
28. Rapid detection of enteroviral RNA in cerebrospinal fluid (CSF) from patients with aseptic meningitis by reverse transcription-nested polymerase chain reaction.
Furione M; Zavattoni M; Gatti M; Percivalle E; Fioroni N; Gerna G
New Microbiol; 1998 Oct; 21(4):343-51. PubMed ID: 9812315
[TBL] [Abstract][Full Text] [Related]
29. Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients.
Labrosse R; Barmettler S; Derfalvi B; Blincoe A; Cros G; Lacombe-Barrios J; Barsalou J; Yang N; Alrumayyan N; Sinclair J; Ong MS; Camargo CA; Walter J; Haddad E
J Allergy Clin Immunol; 2021 Aug; 148(2):523-532.e8. PubMed ID: 33862010
[TBL] [Abstract][Full Text] [Related]
30. Rituximab Use and Hypogammaglobulinemia.
Alhassan E; Johnson J; Nakity R; Shah HZ
Am J Case Rep; 2020 Apr; 21():e920681. PubMed ID: 32269210
[TBL] [Abstract][Full Text] [Related]
31. Stable enterovirus 5' nontranslated region over a 7-year period in a patient with agammaglobulinemia and chronic infection.
Dunn JJ; Romero JR; Wasserman R; Rotbart HA
J Infect Dis; 2000 Jul; 182(1):298-301. PubMed ID: 10882611
[TBL] [Abstract][Full Text] [Related]
32. [Identification of enteroviruses from central nervous system infections by RT-PCR and cell culture methods].
Kılıç I; Altuğlu I; Ciçek C; Pullukçu H; Bayram N; Sirin H; Erensoy S
Mikrobiyol Bul; 2011 Jul; 45(3):468-77. PubMed ID: 21935780
[TBL] [Abstract][Full Text] [Related]
33. Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: a case series.
Roberts DM; Jones RB; Smith RM; Alberici F; Kumaratne DS; Burns S; Jayne DR
J Autoimmun; 2015 Feb; 57():24-9. PubMed ID: 25586449
[TBL] [Abstract][Full Text] [Related]
34. Post-rituximab immunoglobulin M (IgM) hypogammaglobulinemia.
Kridin K; Ahmed AR
Autoimmun Rev; 2020 Mar; 19(3):102466. PubMed ID: 31917267
[TBL] [Abstract][Full Text] [Related]
35. Enteroviral Meningoencephalitis as a Complication of Rituximab Therapy for Rheumatoid Arthritis.
Cook SG; Ford AW; Lindholm DA; Scott J
Cureus; 2021 Sep; 13(9):e18189. PubMed ID: 34707960
[TBL] [Abstract][Full Text] [Related]
36. Chronic aseptic meningitis caused by enterovirus in a humorally immunosuppressed adult patient presenting with sensorineural hearing loss: a case report.
Anderson SM; Gold D; Olson G; Pisano J
BMC Infect Dis; 2022 Jan; 22(1):16. PubMed ID: 34983409
[TBL] [Abstract][Full Text] [Related]
37. Chronic Enterovirus Meningoencephalitis in Prolonged B-Cell Depletion After Rituximab Therapy: Case Report.
Jacksch C; Dargvainiene J; Böttcher S; Diedrich S; Leypoldt F; Stürner K; Berg D; Schäffer E
Neurol Neuroimmunol Neuroinflamm; 2023 Nov; 10(6):. PubMed ID: 37813597
[TBL] [Abstract][Full Text] [Related]
38. Does rituximab aggravate pre-existing hypogammaglobulinaemia?
Diwakar L; Gorrie S; Richter A; Chapman O; Dhillon P; Al-Ghanmi F; Noorani S; Krishna MT; Huissoon A
J Clin Pathol; 2010 Mar; 63(3):275-7. PubMed ID: 20203231
[TBL] [Abstract][Full Text] [Related]
39. [Infections of the central nervous system caused by enterovirus: 223 cases seen at a pediatric hospital between 1973 and 1981].
Thivierge B; Delage G
Can Med Assoc J; 1982 Dec; 127(11):1097-102. PubMed ID: 6291736
[TBL] [Abstract][Full Text] [Related]
40. Life-threatening disseminated enterovirus infection during combined rituximab and ibrutinib maintenance treatment for mantle cell lymphoma: a case report.
Higer M; Cana D; Podlech J; Schadmand-Fischer S; Schwarting A; Teschner D; Theobald M; Wölfel T; Hess G
J Med Case Rep; 2020 Aug; 14(1):135. PubMed ID: 32859260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
